Application and Impact of Run-In Studies for the Evaluation of Statin Efficacy and Safety

被引：0
|
作者：
Michael Fralick
Jerry Avorn
Jessica M. Franklin
Emily Bartsch
Abdurrahman Abdurrob
Aaron S. Kesselheim
机构：
[1] Brigham and Women’s Hospital and Harvard Medical School,Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine
[2] Eliot Phillipson Clinician-Scientist Training Program,Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine
[3] Brigham and Women’s Hospital and Harvard Medical School,undefined
来源：
Journal of General Internal Medicine | 2018年 / 33卷
关键词：
run-in; statin; clinical trial; study design;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：792 / 794
页数：2
相关论文
共 50 条
  • [1] Application and Impact of Run-In Studies for the Evaluation of Statin Efficacy and Safety
    Fralick, Michael
    Avorn, Jerry
    Franklin, Jessica M.
    Bartsch, Emily
    Abdurrob, Abdurrahman
    Kesselheim, Aaron S.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (06) : 792 - 794
  • [2] Application and impact of run-in studies
    Fralick, Michael
    Avorn, Jerry
    Franklin, Jessica M.
    Abdurrob, Abdurrahman
    Kesselheim, Aaron S.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (05) : 759 - 763
  • [3] Application and impact of run-in studies
    Michael Fralick
    Jerry Avorn
    Jessica M. Franklin
    Abdurrahman Abdurrob
    Aaron S. Kesselheim
    [J]. Journal of General Internal Medicine, 2018, 33 : 759 - 763
  • [4] AN EMPIRICAL-EVALUATION OF THE PLACEBO RUN-IN
    DAVIS, CE
    APPLEGATE, WB
    GORDON, DJ
    CURTIS, RC
    MCCORMICK, M
    [J]. CONTROLLED CLINICAL TRIALS, 1995, 16 (01): : 41 - 50
  • [5] ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm
    Moriarty, Patrick M.
    Thompson, Paul D.
    Cannon, Christopher P.
    Guyton, John R.
    Bergeron, Jean
    Zieve, Franklin J.
    Bruckert, Eric
    Jacobson, Terry A.
    Baccara-Dinet, Marie T.
    Zhao, Jian
    Pordy, Robert
    Gipe, Daniel
    [J]. CIRCULATION, 2014, 130 (23) : 2108 - 2109
  • [6] Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia
    Maxwell, Whitney D.
    Ramsey, Laura B.
    Johnson, Samuel G.
    Moore, Kate G.
    Shtutman, Michael
    Schoonover, John H.
    Kawaguchi-Suzuki, Marina
    [J]. PHARMACOTHERAPY, 2017, 37 (09): : 1172 - 1190
  • [7] Efficacy and Safety of Statin
    Wuhanbilige
    [J]. CARDIOLOGY, 2009, 114 : 149 - 150
  • [8] Safety and efficacy of statin therapy
    Adhyaru, Bhavin B.
    Jacobson, Terry A.
    [J]. NATURE REVIEWS CARDIOLOGY, 2018, 15 (12) : 757 - 769
  • [9] Safety and efficacy of statin therapy
    Bhavin B. Adhyaru
    Terry A. Jacobson
    [J]. Nature Reviews Cardiology, 2018, 15 : 757 - 769
  • [10] Run-in periods in randomized trials -: Implications for the application of results in clinical practice
    Pablos-Méndez, A
    Barr, RG
    Shea, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (03): : 222 - 225
12345